Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

External medicine for treating leucoderma

A technology of topical medicine and vitiligo, applied in the direction of drug combination, drug delivery, and medical raw materials derived from gymnosperms, can solve the problems of unpredictable development process, no preventive method, and long treatment period, so as to maintain the efficacy of the drug, Promote the recovery of the disease, the effect of a short course of treatment

Inactive Publication Date: 2019-10-18
江苏博润医疗集团有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the pathogenesis of vitiligo is not yet clear, and its development varies from person to person, and the development process is also difficult to predict. Its treatment is still an international problem
[0003] For this disease, due to the unknown cause, there is no effective preventive method.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0032] Example 1

[0033] An external medicine for the treatment of vitiligo, calculated in parts by weight, comprising: 28 parts of tortoiseshell flowers, 12 parts of psoralen, 15 parts of Polygonum multiflorum, 15 parts of peony, 25 parts of Masson pine flowers, and the rest are auxiliary materials.

[0034] Excipients include glycerol, triethanolamine, gelling agent, dissolving base, distilled water.

[0035] The gelling agent is Carbomer 934.

[0036] Dissolving bases include glyceryl behenate, caprylic glyceride, sorbitan fatty acid ester, polyoxyethylene castor oil.

[0037] A preparation method of an external medicine for treating vitiligo, the steps are as follows:

[0038] S1, respectively by tortoise flower, psoralen, Polygonum multiflorum, peony and masson pine flower dried product pulverization, cross 100 mesh sieves, obtain tortoise tortoise flower powder, psoralen powder, Polygonum multiflorum powder, peony powder and masson pine flower powder;

[0039] S2, weig...

Example Embodiment

[0046] Example 2

[0047] An external medicine for the treatment of vitiligo, calculated in parts by weight, comprising: 20 parts of tortoiseshell flowers, 10 parts of psoralen, 15 parts of Polygonum multiflorum, 15 parts of peony, 25 parts of Masson pine flowers, and the rest are auxiliary materials.

[0048] Excipients include glycerol, triethanolamine, gelling agent, dissolving base, distilled water.

[0049] The gel is Carbomer 940.

[0050] Dissolving bases include glyceryl behenate, caprylic glyceride, sorbitan fatty acid ester, polyoxyethylene castor oil.

[0051] A preparation method of an external medicine for treating vitiligo, the steps are as follows:

[0052] S1, tortoiseshell flower, psoralen, Polygonum multiflorum, peony and masson pine flower dried product are pulverized respectively, cross 80 mesh sieves, obtain tortoise tortoise flower powder, psoralen powder, Polygonum multiflorum powder, peony powder and masson pine flower powder;

[0053] S2, weigh 20 g...

Example Embodiment

[0060] Example 3

[0061] An external medicine for the treatment of vitiligo, calculated in parts by weight, comprising: 30 parts of tortoiseshell flowers, 20 parts of psoralen, 30 parts of Polygonum multiflorum, 20 parts of peony, 35 parts of Masson pine flowers, and the rest are auxiliary materials.

[0062] Excipients include glycerol, triethanolamine, gelling agent, dissolving base, distilled water.

[0063] The gel is Carbomer 941.

[0064] Dissolving bases include glyceryl behenate, caprylic glyceride, sorbitan fatty acid ester, polyoxyethylene castor oil.

[0065] A preparation method of an external medicine for treating vitiligo, the steps are as follows:

[0066] S1, respectively by tortoise flower, psoralen, Polygonum multiflorum, peony and masson pine flower dried product pulverization, cross 90 mesh sieves, obtain tortoise tortoise flower powder, psoralen powder, Polygonum multiflorum powder, peony powder and masson pine flower powder;

[0067] S2, weigh 30 g of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicines, in particular to the field of external medicines for treating leucoderma. The invention discloses an external medicine for treating leucoderma comprises, by weight, 20-30 parts of citrus aurantium, 10-20 parts of fructus psoraleae, 15-30 parts of polygonum multiflorum, 10-20 parts of Chinese herbaceous peony, 25-35 parts of masson pine flowers and the balance auxiliary materials. The problems that existing traditional Chinese medicines are long in treatment course, slow in effect and not remarkable in effect are solved. After smearing, the prepared external medicine for treating leucoderma can be quickly absorbed and utilized by skin, and the medicine can be kept for a long time on the skin so that recovery of diseases can be promoted, the medicine takes effect quickly and is remarkable in effect, and the treatment course is correspondingly shortened.

Description

technical field [0001] The invention relates to the field of medicines, in particular to the field of externally used medicines for treating vitiligo. Background technique [0002] Vitiligo (vitiligo) is an acquired depigmentation skin disease, which is characterized by localized or generalized depigmentation of the skin due to the hypofunction and loss of the melanocyte endogenous system of the skin and hair follicles. Disease, also known as "Vitiligo", "White Spot", "White Spot", etc. in Chinese medicine. According to statistics, the incidence of vitiligo is about 2%, that is, about 120 million people in the world population suffer from this disease. At present, the pathogenesis of vitiligo is not yet clear, and its development varies from person to person, and the development process is also difficult to predict. Its treatment is still an international problem. [0003] For this disease, because the cause of formation is unknown, there is no effective preventive method....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/752A61K9/06A61K47/10A61P17/00
CPCA61K9/0014A61K9/06A61K36/15A61K36/487A61K36/65A61K36/704A61K36/71A61K36/752A61K47/10A61K2236/331A61P17/00A61K2300/00
Inventor 陈国森陈元寿
Owner 江苏博润医疗集团有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com